Literature DB >> 7849154

Impending and actual pathological fractures in patients with bone metastases of the long bones. A retrospective study of 233 surgically treated fractures.

S Dijstra1, T Wiggers, B N van Geel, H Boxma.   

Abstract

OBJECTIVE: Analysis of short-term and long-term complications after cemented osteosynthesis for pathological fractures.
DESIGN: Retrospective study.
SETTING: South Municipal Hospital and the Daniël den Hoed Cancer Centre, Rotterdam, The Netherlands.
SUBJECTS: 199 patients consecutive surgically treated between 1978 to 1990 for 233 fractures (161 actual and 72 impending) caused by metastatic lesions of the femur, humerus and tibia.
INTERVENTIONS: Local resection of the tumour was followed by endoprostheses (n = 52) and by internal plate osteosynthesis (n = 167); 14 fractures were treated with intramedullary nails. Bone cement was added in 211 cases (91%). MAIN OUTCOME MEASURES: Pain relief, mobilisation, complications.
RESULTS: Pain relief was achieved in about 90%. 145 (76%) who were treated for fractures of the lower extremity were able to walk again. There were 13 local complications: 26 (11%) implanted devices failed (cumulative probability 40%, after 60 months). In 11 cases the fixation failed after 7 weeks. The failure rate was 16% in the subtrochanteric region treated with an angled blade (probability 70% after four years). The patients' survival rate was 55% after six months and 20% at two years.
CONCLUSION: Despite the poor life expectancy, our results indicate that hemiarthroplasty or osteosynthesis with bone cement for treatment of pathological (impending) fractures is a safe way to restore limb function and to improve quality of life.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7849154

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  30 in total

Review 1.  Outcome of operative treatment of metastatic fractures of the humerus: a systematic review of twenty three clinical studies.

Authors:  Stein J Janssen; Teun Teunis; Francis J Hornicek; Jos A M Bramer; Joseph H Schwab
Journal:  Int Orthop       Date:  2014-11-16       Impact factor: 3.075

2.  Subtrochanteric metastatic lesions treated with the long gamma nail.

Authors:  S R Samsani; V Panikkar; D Georgiannos; D Calthorpe
Journal:  Int Orthop       Date:  2003-06-11       Impact factor: 3.075

3.  Should the Use of Biologic Agents in Patients With Renal and Lung Cancer Affect Our Surgical Management of Femoral Metastases?

Authors:  Christina J Gutowski; Benjamin Zmistowski; Nicola Fabbri; Patrick J Boland; John H Healey
Journal:  Clin Orthop Relat Res       Date:  2019-04       Impact factor: 4.176

4.  Surgical management of metastatic lesions of the proximal femur with pathological fractures using intramedullary nailing or endoprosthetic replacement.

Authors:  Zeping Yu; Yan Xiong; Rui Shi; Li Min; Wenli Zhang; Hongyuan Liu; Xiang Fang; Chongqi Tu; Hong Duan
Journal:  Mol Clin Oncol       Date:  2017-11-15

Review 5.  [Prognosis-adapted surgical management of bone metastases].

Authors:  S Utzschneider; P Weber; A Fottner; B Wegener; V Jansson; H R Dürr
Journal:  Orthopade       Date:  2009-04       Impact factor: 1.087

6.  Inter- and intra-observer variability associated with the use of the Mirels' scoring system for metastatic bone lesions.

Authors:  Ruairi F Mac Niocaill; John F Quinlan; Robert D Stapleton; Brian Hurson; Sean Dudeney; Gary C O'Toole
Journal:  Int Orthop       Date:  2010-01-19       Impact factor: 3.075

7.  Minimally invasive treatment of pathological fractures of the humeral shaft.

Authors:  Onder Ofluoglu; Bulent Erol; Zerrin Ozgen; Muzaffer Yildiz
Journal:  Int Orthop       Date:  2008-04-03       Impact factor: 3.075

8.  Percutaneous long bone cementoplasty of the limbs: experience with fifty-one non-surgical patients.

Authors:  Roberto Luigi Cazzato; Xavier Buy; Omer Eker; Thierry Fabre; Jean Palussiere
Journal:  Eur Radiol       Date:  2014-08-06       Impact factor: 5.315

9.  Trends in the surgical treatment of pathologic proximal femur fractures among Musculoskeletal Tumor Society members.

Authors:  Matthew Steensma; John H Healey
Journal:  Clin Orthop Relat Res       Date:  2012-12-18       Impact factor: 4.176

10.  Update in palliative management of hormone refractory cancer of prostate.

Authors:  Pratipal Singh; Aneesh Srivastava
Journal:  Indian J Urol       Date:  2007-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.